
Annual report 2021
added 12-23-2023
Burning Rock Biotech Limited Market Cap 2011-2026 | BNR
As of March 04, 2026 Burning Rock Biotech Limited has a market cap of $ 243 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 2.95 B | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.95 B | 2.95 B | 2.95 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
42 B | $ 120.47 | 1.2 % | $ 36.6 B | ||
|
Anixa Biosciences
ANIX
|
104 K | $ 2.9 | 2.47 % | $ 94.1 K | ||
|
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | ||
|
Celcuity
CELC
|
399 M | $ 108.86 | 1.36 % | $ 4.29 B | ||
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
709 M | $ 27.97 | 1.43 % | $ 777 M | ||
|
Fulgent Genetics
FLGT
|
467 M | $ 14.17 | 2.72 % | $ 428 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M | ||
|
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | ||
|
Charles River Laboratories International
CRL
|
7.69 B | $ 179.12 | 1.95 % | $ 8.88 B | ||
|
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | ||
|
IDEXX Laboratories
IDXX
|
51.1 B | $ 638.42 | 0.62 % | $ 51.3 B | ||
|
Illumina
ILMN
|
16.4 B | $ 131.73 | 1.67 % | $ 20.9 B | ||
|
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | ||
|
Laboratory Corporation of America Holdings
LH
|
23.9 B | $ 282.44 | -0.19 % | $ 23.5 B | ||
|
Lantheus Holdings
LNTH
|
5.12 B | $ 79.34 | 0.63 % | $ 5.35 B | ||
|
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
92.1 M | $ 15.04 | -2.97 % | $ 1.95 B | ||
|
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | ||
|
Mettler-Toledo International
MTD
|
28.4 B | $ 1 319.33 | 0.2 % | $ 27.2 B | ||
|
Myriad Genetics
MYGN
|
409 M | $ 5.43 | 2.65 % | $ 503 M | ||
|
Invitae Corporation
NVTA
|
511 M | - | - | $ 21.2 M | ||
|
NeoGenomics
NEO
|
1.48 B | $ 9.65 | 1.1 % | $ 1.24 B | ||
|
BioNano Genomics
BNGO
|
3.55 M | $ 1.12 | - | $ 1.42 M | ||
|
Quest Diagnostics Incorporated
DGX
|
23.3 B | $ 209.29 | 0.44 % | $ 23.2 B | ||
|
Danaher Corporation
DHR
|
150 B | $ 204.98 | 0.48 % | $ 146 B | ||
|
National Research Corporation
NRC
|
1.01 B | $ 13.39 | - | $ 329 M | ||
|
Organovo Holdings
ONVO
|
3.1 M | - | -2.3 % | $ 19.4 M | ||
|
Exact Sciences Corporation
EXAS
|
19.5 B | $ 103.46 | 0.09 % | $ 19.5 B | ||
|
Bioventus
BVS
|
351 M | $ 8.57 | -1.95 % | $ 537 M | ||
|
OPKO Health
OPK
|
1.21 B | $ 1.21 | 1.68 % | $ 840 M | ||
|
DarioHealth Corp.
DRIO
|
43.4 M | $ 10.5 | 1.94 % | $ 298 M | ||
|
DexCom
DXCM
|
25.5 B | $ 71.55 | -2.09 % | $ 27.9 B | ||
|
PerkinElmer
PKI
|
14.1 B | - | -0.91 % | $ 14.7 B | ||
|
Pacific Biosciences of California
PACB
|
498 M | $ 1.62 | 6.25 % | $ 486 M | ||
|
Psychemedics Corporation
PMD
|
16.8 M | - | -1.84 % | $ 15.3 M | ||
|
QIAGEN N.V.
QGEN
|
8.52 B | - | - | $ 10.6 B | ||
|
ICON Public Limited Company
ICLR
|
16.6 B | $ 111.03 | 2.14 % | $ 9.16 B | ||
|
Quotient Limited
QTNT
|
183 M | - | -11.32 % | $ 1.1 M | ||
|
Precipio
PRPO
|
8.7 M | $ 25.4 | 1.7 % | $ 33 M | ||
|
Renalytix AI plc
RNLX
|
22.7 M | - | 5.66 % | $ 22.7 M | ||
|
CareDx, Inc
CDNA
|
993 M | $ 19.2 | 2.13 % | $ 1.02 B | ||
|
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M |